(Q33362997)

English

A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer

scientific article

Statements

A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer (English)
Miguel A Villalona-Calero
Jose A Figueroa
Gregory A Otterson
Sebastian George
James Leonardo
Spence McCachren
G Lance Miller
Manuel Modiano
Manuel Valdivieso
Richard Geary
Jennifer W Oliver
Jon Holmlund
1 September 2004
6086-6093

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit